Humacyte Appoints Two Life Science Veterans to Board of Directors
Humacyte adds Scott Coward and Paul Kuznik to its board, bolstering the company's commercialization and global operations capabilities as it continues to…
Humacyte adds Scott Coward and Paul Kuznik to its board, bolstering the company's commercialization and global operations capabilities as it continues to…
GPN Vaccines showcases clinical advancements for its Gamma-PN and Gamma-SU platforms, signaling progress in its mission to develop broadly protective vaccines for…
Biogen shares trade near 52-week highs as strong commercial momentum and a robust pipeline of Phase 3 readouts drive the stock to…
Parabilis completes $745 million US IPO, indicating robust biotech investor appetite and potential gains for biotech ETFs.